Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 11:03 am Purchase | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | VANGUARD GROUP INC | 5,131,197 7.980% | 1,606,998 (+45.60%) | Filing History |
| 2021-02-05 06:10 am Sale | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | Sumitomo Mitsui Trust Holdings Inc. | 5,104,362 7.940% | -318,856 (-5.88%) | Filing History |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | BlackRock Inc. BLK | 5,052,845 8.600% | 1,407,615 (+38.62%) | Filing History |
| 2021-01-22 4:59 pm Sale | 2021-01-21 | 13D | Intellia Therapeutics, Inc. NTLA | Novartis Institutes for BioMedical Research Inc. | 2,176,148 3.700% | -2,176,147 (-50.00%) | Filing History |
| 2020-12-09 06:01 am Sale | 2020-11-30 | 13G | Intellia Therapeutics, Inc. NTLA | Sumitomo Mitsui Trust Holdings Inc. | 5,423,218 9.180% | -1,755,302 (-24.45%) | Filing History |
| 2020-12-08 4:26 pm Sale | 2020-11-30 | 13G | Intellia Therapeutics, Inc. NTLA | Nikko Asset Management Americas Inc. | 5,423,218 9.180% | -1,755,302 (-24.45%) | Filing History |
| 2020-08-20 4:30 pm Unchanged | 2020-08-06 | 13D | Intellia Therapeutics, Inc. NTLA | Novartis Institutes for BioMedical Research Inc. | 4,352,295 7.400% | 0 (Unchanged) | Filing History |